返回
Scienture Holdings Inc（SCNX）价格
SCNX 股价走势图
SCNX 收益
Scienture Holdings Inc
$0.53
1.39%
$0
收盘价：Jan 16, 16:00:00 GMT-5
$0.51
-1.9%
$-0.01
盘后：Jan 16, 20:00:00 GMT-5
关键数据
前收盘价
$0.5227
开盘价
$0.5144
当日区间
$0.509 - $0.53
52周范围
$0.461 - $4.5
交易量
606.0K
平均成交量
21.0M
每股收益（TTM）
-1.72
股息收益率
10.70%
市值
$21.1M
什么是 SCNX？
Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. The company is headquartered in Commack, New York and currently employs 14 full-time employees. The company went IPO on 2020-02-18. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The firm's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.